Mutual of America Capital Management LLC Has $4.70 Million Stock Holdings in Chemed Co. (NYSE:CHE)

Mutual of America Capital Management LLC lowered its position in shares of Chemed Co. (NYSE:CHE) by 11.4% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,669 shares of the company’s stock after selling 1,114 shares during the quarter. Mutual of America Capital Management LLC owned 0.06% of Chemed worth $4,704,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Principal Securities Inc. bought a new position in Chemed in the fourth quarter valued at $51,000. Norges Bank acquired a new position in shares of Chemed during the 4th quarter worth about $92,359,000. Corient Private Wealth LLC grew its holdings in shares of Chemed by 7.9% in the 4th quarter. Corient Private Wealth LLC now owns 2,741 shares of the company’s stock valued at $1,603,000 after acquiring an additional 200 shares in the last quarter. Trexquant Investment LP acquired a new stake in shares of Chemed in the fourth quarter valued at about $3,254,000. Finally, Franklin Resources Inc. raised its holdings in Chemed by 45.4% during the fourth quarter. Franklin Resources Inc. now owns 9,861 shares of the company’s stock worth $5,766,000 after acquiring an additional 3,077 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Stock Down 0.5 %

CHE stock opened at $582.06 on Friday. The company has a market cap of $8.81 billion, a price-to-earnings ratio of 31.33, a P/E/G ratio of 2.31 and a beta of 0.44. Chemed Co. has a twelve month low of $497.36 and a twelve month high of $654.62. The business has a 50 day moving average price of $569.34 and a two-hundred day moving average price of $577.64.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The firm had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same period in the prior year, the business posted $4.71 earnings per share. Chemed’s quarterly revenue was up 7.6% compared to the same quarter last year. On average, equities research analysts anticipate that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. This is a boost from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. Chemed’s dividend payout ratio is presently 10.76%.

Insider Activity at Chemed

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares in the company, valued at $3,363,864.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the transaction, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at $3,363,864.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the sale, the director now owns 5,725 shares of the company’s stock, valued at approximately $3,271,894.75. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,744 shares of company stock worth $3,828,231. Insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.